129 filings
Page 3 of 7
8-K
x31o4z6brfpgh94nw
10 Mar 23
Regulation FD Disclosure
7:02pm
S-8
cqct2pfc2vncuh2s
6 Mar 23
Registration of securities for employees
4:08pm
8-K
9yf813yj07 9cbocj
6 Mar 23
Inhibrx Reports Fourth Quarter and Fiscal Year 2022 Financial Results
4:04pm
8-K
wef7ge
16 Nov 22
Regulation FD Disclosure
9:01am
8-K
lsjnr1lcos2qpkm8g
7 Nov 22
Inhibrx Reports Third Quarter 2022 Financial Results
4:05pm
8-K
y1p3t62
26 Oct 22
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:10pm
UPLOAD
20zw2r
5 Oct 22
Letter from SEC
12:00am
8-K
dnu2xy gswyt
4 Oct 22
Entry into a Material Definitive Agreement
8:02am
CORRESP
12hy5h8jcrwex
23 Sep 22
Correspondence with SEC
12:00am
UPLOAD
rlkyr1s60gs4dm8vx57
15 Sep 22
Letter from SEC
12:00am
8-K
i6csfr wj4m
15 Aug 22
European Medicines Agency Grants Orphan Drug Designation to INBRX-109 for the Treatment of Chondrosarcoma
4:09pm
8-K
tw54alqmyfdxu12loo
10 Aug 22
Regulation FD Disclosure
4:06pm
8-K
j54x 961f5o
8 Aug 22
Inhibrx Reports Second Quarter 2022 Financial Results
4:19pm
8-K
fagtfkwvuy600rqjp
30 Jun 22
Regulation FD Disclosure
9:01am
8-K
b1zmtvh 6lpprh9hdted
16 Jun 22
Entry into a Material Definitive Agreement
4:05pm
8-K
esu202ojr1uun3d d2ar
25 May 22
Submission of Matters to a Vote of Security Holders
5:23pm
8-K
ofy48hut7pmnv
16 May 22
Regulation FD Disclosure
9:03am